| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Huang Chia-Yu | 9 |
| #2 | Letourneau Jeffrey J | 6 |
| #3 | Mcguinness Brian F | 6 |
| #4 | Cole Andrew G | 4 |
| #5 | Kultgen Steven G | 4 |
| #6 | Beasley James R | 4 |
| #7 | Stein Philip D | 3 |
| #8 | Paget Steven | 2 |
| #9 | Marinelli Brett A | 2 |
| #10 | Bommireddy Venkata Venugopalareddy | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2021060041A1 | Sting agonists for treating bladder cancer and solid tumors | |
| US2021015829A1 | Cyclic trex1 inhibitors | |
| WO2020210032A1 | Novel cyclic trex1 inhibitors | |
| US2020131209A1 | Novel sting agonists | |
| WO2018005794A2 | Novel non-systemic tgr5 agonists | |
| US2020308122A1 | Novel non-systemic tgr5 agonists | |
| WO2017214359A1 | Novel clostridium difficile toxin inhibitors |